As a marker of fibrosis, galectin-3 also expresses the effectiveness of the cardioprotective nature of spironolactone in children with chronic heart failure due to congenital heart diseases in whom anti-aldosterone therapy is conducted broadly as a prophylaxis against pathological remodeling of the myocardium [19]. This evidence concerns the gene LGALS3 and congestive heart failure.